{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:33:52Z","timestamp":1787776432347,"version":"build-2784847793"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08EY031759"],"award-info":[{"award-number":["K08EY031759"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"abstract":"<jats:p>Collaborations between ophthalmologists and infectious disease specialists are critical for optimizing care of many patients with eye infections. We review challenges in common and uncommon eye infections to promote better understanding of these infections and prioritize areas for further research.<\/jats:p>","DOI":"10.1093\/cid\/ciae433","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:06:28Z","timestamp":1732233988000},"page":"e48-e64","source":"Crossref","is-referenced-by-count":9,"title":["State-of-the-Art Review: Ocular Infections"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3244-9366","authenticated-orcid":false,"given":"Miriam B","family":"Barshak","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene L","family":"Durand","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Ophthalmology, Massachusetts Eye and Ear , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Mass General Brigham Medical Group , Haverhill, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir M","family":"Mohareb","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Dohlman","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N","family":"Papaliodis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Ophthalmology, Massachusetts Eye and Ear , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"2024112200061602900_ciae433-B1"},{"key":"2024112200061602900_ciae433-B2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diagnostics12010134","article-title":"Review of machine learning applications using retinal fundus images","volume":"12","author":"Jeong","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2024112200061602900_ciae433-B3"},{"key":"2024112200061602900_ciae433-B4","first-page":"372","article-title":"Conjunctivitis: a systematic review","volume":"15","author":"Azari","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"key":"2024112200061602900_ciae433-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2024112200061602900_ciae433-B6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jinf.2019.10.015","article-title":"Primary meningococcal conjunctivitis: summary of evidence for the clinical and public health management of cases and close contacts","volume":"79","author":"Parikh","year":"2019","journal-title":"J Infect"},{"key":"2024112200061602900_ciae433-B7","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMra2216081","article-title":"Eye infections","volume":"389","author":"Durand","year":"2023","journal-title":"N Engl J Med"},{"key":"2024112200061602900_ciae433-B8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMc2307114","article-title":"Case 14-2023: a man with redness of the right eye","volume":"389","author":"Kiernan","year":"2023","journal-title":"N Engl J Med"},{"key":"2024112200061602900_ciae433-B9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtos.2022.04.003","article-title":"Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach","volume":"25","author":"Kaufman","year":"2022","journal-title":"Ocul Surf"},{"key":"2024112200061602900_ciae433-B10","author":"American Academy of Ophthalmology"},{"key":"2024112200061602900_ciae433-B11","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0161-6420(94)31087-6","article-title":"Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis","volume":"101","author":"Wilhelmus","year":"1994","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B12"},{"key":"2024112200061602900_ciae433-B13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.15585\/mmwr.mm6432a2","article-title":"Contact lens wearer demographics and risk behaviors for contact lens-related eye infections\u2014United States, 2014","volume":"64","author":"Cope","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024112200061602900_ciae433-B14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/cid\/ciae052","article-title":"Extensively drug-resistant Pseudomonas aeruginosa outbreak associated with artificial tears","volume":"79","author":"Grossman","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B15","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S1473-3099(20)30448-5","article-title":"The global incidence and diagnosis of fungal keratitis","volume":"21","author":"Brown","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024112200061602900_ciae433-B16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024112200061602900_ciae433-B17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/ICO.0000000000003218","article-title":"Corneal transplantation for infectious keratitis: a prospective Dutch Registry Study","volume":"42","author":"Veugen","year":"2023","journal-title":"Cornea"},{"key":"2024112200061602900_ciae433-B18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jtos.2021.09.005","article-title":"Surgical management of infectious keratitis","volume":"28","author":"Said","year":"2023","journal-title":"Ocul Surf"},{"key":"2024112200061602900_ciae433-B19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/08820538.2010.518895","article-title":"Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies","volume":"25","author":"Traish","year":"2010","journal-title":"Semin Ophthalmol"},{"key":"2024112200061602900_ciae433-B20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12348-015-0054-z","article-title":"Multimodal imaging of refractory Candida chorioretinitis progressing to endogenous endophthalmitis","volume":"5","author":"Lavine","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2024112200061602900_ciae433-B21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2008.10.023","article-title":"Low rate of endophthalmitis in a large series of open globe injuries","volume":"147","author":"Andreoli","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"2024112200061602900_ciae433-B22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09273948.2016.1207788","article-title":"Treatment of refractory acute retinal necrosis with intravenous foscarnet or cidofovir","volume":"26","author":"Stryjewski","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B23","doi-asserted-by":"crossref","first-page":"e00057-17","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"2024112200061602900_ciae433-B24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/09273948.2022.2061521","article-title":"Hypervirulent Klebsiella Pneumoniae, an emerging cause of endogenous endophthalmitis in a French center: a comparative cohort study","volume":"31","author":"Martellosio","year":"2023","journal-title":"Ocul Immunol Inflammation"},{"key":"2024112200061602900_ciae433-B26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cmi.2019.01.017","article-title":"Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics","volume":"25","author":"Brockhaus","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2024112200061602900_ciae433-B27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.survophthal.2014.06.002","article-title":"Systematic review of 342 cases of endogenous bacterial endophthalmitis","volume":"59","author":"Jackson","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"2024112200061602900_ciae433-B28","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cid\/ciad064","article-title":"Prevalence of ocular candidiasis and Candida endophthalmitis in patients with candidemia: a systematic review and meta-analysis","volume":"76","author":"Phongkhun","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B29"},{"key":"2024112200061602900_ciae433-B30","doi-asserted-by":"crossref","first-page":"e0222356","DOI":"10.1371\/journal.pone.0222356","article-title":"Risk factors and outcomes of patients with ocular involvement of candidemia","volume":"14","author":"Son","year":"2019","journal-title":"PLoS One"},{"key":"2024112200061602900_ciae433-B31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2021.07.015","article-title":"American Academy of Ophthalmology recommendations on screening for endogenous Candida endophthalmitis","volume":"129","author":"Breazzano","year":"2022","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/ciz804","article-title":"Infectious complications of addiction: a call for a new subspecialty within infectious diseases","volume":"70","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B33","first-page":"48","article-title":"Aspergillus endophthalmitis in intravenous-drug users\u2014Kentucky","volume":"39","author":"Centers for Disease Control and Prevention (CDC)","year":"1990","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024112200061602900_ciae433-B34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaophthalmol.2017.0650","article-title":"An outbreak of endogenous fungal endophthalmitis among intravenous drug abusers in New England","volume":"135","author":"Tirpack","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2024112200061602900_ciae433-B35","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/IAE.0b013e3181dd6db6","article-title":"Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center","volume":"30","author":"Connell","year":"2010","journal-title":"Retina"},{"key":"2024112200061602900_ciae433-B36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oret.2016.10.013","article-title":"Intravenous drug use-associated endophthalmitis","volume":"1","author":"Modjtahedi","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"2024112200061602900_ciae433-B37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijid.2014.01.019","article-title":"Bacillus cereus panophthalmitis associated with injection drug use","volume":"26","author":"Kumar","year":"2014","journal-title":"Int J Infect Dis"},{"key":"2024112200061602900_ciae433-B38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0009-9236(98)90089-3","article-title":"The effect of fluconazole on the clinical pharmacokinetics of methadone","volume":"63","author":"Cobb","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"2024112200061602900_ciae433-B39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0885-3924(01)00368-2","article-title":"Methadone and fluconazole: respiratory depression by drug interaction","volume":"23","author":"Tarumi","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"2024112200061602900_ciae433-B40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jat\/bkv030","article-title":"Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism","volume":"39","author":"Moody","year":"2015","journal-title":"J Anal Toxicol"},{"key":"2024112200061602900_ciae433-B41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtcvs.2021.10.048","article-title":"Multidisciplinary team approach to confront the challenge of drug use-associated infective endocarditis","volume":"166","author":"Paras","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024112200061602900_ciae433-B42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/ADM.0000000000000916","article-title":"The need for multidisciplinary hospital teams for injection drug use-related infective endocarditis","volume":"16","author":"Weimer","year":"2022","journal-title":"J Addict Med"},{"key":"2024112200061602900_ciae433-B43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/IIO.0000000000000415","article-title":"Challenges and updates on the management of acute retinal necrosis","volume":"62","author":"Lains","year":"2022","journal-title":"Int Ophthalmol Clin"},{"key":"2024112200061602900_ciae433-B44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(96)30632-5","article-title":"Detection of Epstein-Barr virus genome in ocular tissues","volume":"103","author":"Chodosh","year":"1996","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/eye.1995.53","article-title":"Progressive outer retinal necrosis (PORN) in AIDS patients: a different appearance of varicella-zoster retinitis","volume":"9","author":"Pavesio","year":"1995","journal-title":"Eye (Lond)"},{"key":"2024112200061602900_ciae433-B46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00915966","article-title":"The progressive outer retinal necrosis syndrome","volume":"18","author":"Holland","year":"1994","journal-title":"Int Ophthalmol"},{"key":"2024112200061602900_ciae433-B47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2007.11.016","article-title":"Vitreous penetration of orally administered valacyclovir","volume":"145","author":"Huynh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"2024112200061602900_ciae433-B48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3928\/23258160-20140908-02","article-title":"Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome","volume":"45","author":"Yeh","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2024112200061602900_ciae433-B49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2016.11.007","article-title":"Diagnosis and treatment of acute retinal necrosis: a report by the American Academy of Ophthalmology","volume":"124","author":"Schoenberger","year":"2017","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/eye.2011.338","article-title":"Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study","volume":"26","author":"Cochrane","year":"2012","journal-title":"Eye (Lond)"},{"key":"2024112200061602900_ciae433-B51","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2147\/OPTH.S258488","article-title":"Management strategies of acute retinal necrosis: current perspectives","volume":"14","author":"Powell","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"2024112200061602900_ciae433-B52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int J Parasitol"},{"key":"2024112200061602900_ciae433-B53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2024112200061602900_ciae433-B54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10792-012-9634-1","article-title":"Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial","volume":"33","author":"Baharivand","year":"2013","journal-title":"Int Ophthalmol"},{"key":"2024112200061602900_ciae433-B56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0161-6420(99)90021-0","article-title":"Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients","volume":"106","author":"Pearson","year":"1999","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.joco.2016.10.002","article-title":"A prospective randomized trial of azithromycin versus trimethoprim\/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis","volume":"29","author":"Lashay","year":"2016","journal-title":"J Curr Ophthalmol"},{"key":"2024112200061602900_ciae433-B58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajo.2019.12.025","article-title":"Long-term results of trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrent Toxoplasma gondii retinochoroiditis","volume":"213","author":"Fernandes Felix","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"2024112200061602900_ciae433-B59","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.15585\/mmwr.mm6543a2","article-title":"Ocular syphilis\u2014eight jurisdictions, United States, 2014\u20132015","volume":"65","author":"Oliver","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024112200061602900_ciae433-B60","author":"Centers for Disease Control and Prevention"},{"key":"2024112200061602900_ciae433-B61","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/cid\/ciaa180","article-title":"Prevalence of self-reported neurologic and ocular symptoms in early syphilis cases","volume":"72","author":"Quilter","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/sti.2010.043042","article-title":"Ocular syphilis among HIV-infected patients: a systematic analysis of the literature","volume":"87","author":"Tucker","year":"2011","journal-title":"Sex Transm Infect"},{"key":"2024112200061602900_ciae433-B63","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae354","article-title":"Ocular syphilis in patients with nonreactive RPR and positive treponemal serologies: a retrospective observational cohort study","author":"Mohareb","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B64","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/cid\/ciaa306","article-title":"Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests","volume":"71","author":"Tuddenham","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024112200061602900_ciae433-B65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/sextrans-2016-052570","article-title":"Ocular syphilis: opportunities to address important unanswered questions","volume":"92","author":"Tuddenham","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2024112200061602900_ciae433-B66","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S1473-3099(20)30857-4","article-title":"Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study","volume":"21","author":"Bettuzzi","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024112200061602900_ciae433-B67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00130924","article-title":"Ocular morbidity in patients with active systemic tuberculosis","volume":"19","author":"Biswas","year":"1995","journal-title":"Int Ophthalmol"},{"key":"2024112200061602900_ciae433-B68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09273948.2017.1406529","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends","volume":"27","author":"Agarwal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis\u2014report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis\u2014report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B71","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/09273948.2021.1992446","article-title":"The historical evolution of ocular tuberculosis: past, present, and future","volume":"30","author":"Betzler","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B72","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/jcm8091392","article-title":"The eye as a window to systemic infectious diseases: old enemies, new imaging","volume":"8","author":"Pirani","year":"2019","journal-title":"J Clin Med"},{"key":"2024112200061602900_ciae433-B73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09273948.2018.1489061","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis","volume":"28","author":"Agrawal","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B74","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.ophtha.2012.05.034","article-title":"Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis","volume":"119","author":"Bansal","year":"2012","journal-title":"Ophthalmology"},{"key":"2024112200061602900_ciae433-B75","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/09273948.2012.723236","article-title":"Distinctive clinical features of idiopathic versus infectious serpiginous choroidopathy","volume":"20","author":"Carre\u00f1o","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0039-6257(93)90076-J","article-title":"Ocular tuberculosis","volume":"38","author":"Helm","year":"1993","journal-title":"Surv Ophthalmol"},{"key":"2024112200061602900_ciae433-B77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jfo.2016.09.012","article-title":"Steroid treatment in ocular tuberculosis: a double-edged sword?","volume":"40","author":"Souissi","year":"2017","journal-title":"J Fr Ophtalmol"},{"key":"2024112200061602900_ciae433-B78","first-page":"237","article-title":"Ocular tuberculosis\u2014a clinical conundrum","volume":"24","author":"Lee","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B79","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/09273948.2022.2027459","article-title":"Role of interferon-gamma release assay for the diagnosis and clinical follow up in ocular tuberculosis","volume":"31","author":"Fern\u00e1ndez-Zamora","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B80","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3341\/kjo.2014.28.3.226","article-title":"The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea","volume":"28","author":"Ahn","year":"2014","journal-title":"Korean J Ophthalmol"},{"key":"2024112200061602900_ciae433-B81","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/bjophthalmol-2014-306285","article-title":"Cost-effectiveness of alternative strategies for interferon-\u03b3 release assays and tuberculin skin test in tuberculous uveitis","volume":"99","author":"Ang","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"2024112200061602900_ciae433-B82","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2024112200061602900_ciae433-B83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00006982-199515060-00001","article-title":"Intraocular tuberculosis. Clinicopathologic study of five cases","volume":"15","author":"Biswas","year":"1995","journal-title":"Retina"},{"key":"2024112200061602900_ciae433-B84","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.7150\/thno.81488","article-title":"Diagnosis and biomarkers for ocular tuberculosis: from the present into the future","volume":"13","author":"Ludi","year":"2023","journal-title":"Theranostics"},{"key":"2024112200061602900_ciae433-B85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40794-023-00205-w","article-title":"Ocular manifestations and diagnosis of tuberculosis involving the uvea: a case series","volume":"9","author":"Tsui","year":"2023","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"2024112200061602900_ciae433-B86","doi-asserted-by":"crossref","first-page":"ofv195","DOI":"10.1093\/ofid\/ofv195","article-title":"Role of the infectious disease consultant in management of patients with tuberculosis-associated ocular inflammation","volume":"3","author":"Conant","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2024112200061602900_ciae433-B87","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/09273948.2015.1019155","article-title":"Moxifloxacin: an alternative to ethambutol for the treatment of presumed ocular tuberculosis","volume":"24","author":"Potter","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"2024112200061602900_ciae433-B88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12348-019-0183-x","article-title":"Paradoxical reactions in ocular tuberculosis","volume":"9","author":"Ganesh","year":"2019","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/5\/e48\/60779401\/ciae433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/5\/e48\/60779401\/ciae433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:06:47Z","timestamp":1732234007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/79\/5\/e48\/7906406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":88,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11,19]]},"published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae433","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11,15]]},"published":{"date-parts":[[2024,11,15]]}}}